University of California San Francisco
Give to UCSF
Four UCSF faculty members will each receive over $2 million in total over the next five years as members of the 2026 class of New Innovators in the Common Fund’s High-Risk, High-Reward Research (HRHRR) program.
UCSF researchers discover how some of our hardest-working organs stay healthy: by recruiting immune macrophages to dispose of spent batteries (mitochondria) while heart/muscle/fat cells burn energy.
Teams of researchers at UCSF discover how C. auris, a fungal superbug that can make a difficult hospitalization deadly, stows itself in hair follicles to evade the skin's typical immune defenses.
UCSF Health’s Adam Blaisdell, MD, PhD, has been selected as an IGNITE fellow by the Cancer Research Institute (CRI), a New York-based nonprofit that funds and promotes cancer immunotherapy research.
UCSF researchers are using tiny "mini-organs" to model disease, personalize treatment, and understand human development. They are also addressing the limitations holding the field back: giving organoids a vascular system and making organoids reproducible.
A new UCSF study looks at the real reasons women with HIV are dying earlier than people without HIV, and finds these leading causes are largely missing from official death records.
Jody Baron and Gabi Fragiadakis discover why some people with chronic Hepatitis B are cured after they're taken off of antiviral drugs, despite falling severely ill when the drug regiment stops.
UCSF expert Charles Chiu discusses rising measles cases, extreme contagiousness, and why 95% vaccination rates are vital for community safety.
UCSF research led to the first type 1 diabetes immunotherapy. Now, scientists are using stem cells and Tregs to find a functional cure.
Why are the elderly so much more likely to get sick and hospitalized for pneumonia and COVID? UCSF scientists found that old lung cells overreact to infections, inviting immune attack and runaway inflammation.
A new study traces the molecular pathway connecting the gut immune system to the brain during a parasitic infection, explaining how the immune system triggers a loss of appetite.
A UCSF team discovers that a notorious cancer-causing enzyme called SRC exists on the outside of many tumors - so they're turning it into a cancer drug.
A study from UCSF shows a previously unknown connection between the Epstein-Barr virus, known to play a role in MS, and an understudied type of immune cell.
At the new Weill Cancer Hub West, Kole Roybal, PhD, is reimagining how immune cells fight solid tumors.
Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment by using a patient’s own T-cells to target tumors. However, they can cause rare but potentially fatal cardiac inflammation
Late-breaking results from clinical trials, debates about lifestyle choices and cardiovascular risk, and improving clinical care with generative AI are among the topics being presented by UC San
Senescent fibroblasts are aging cells in connective tissue that no longer divide and protect against tumor development. Yet, these same cells can promote cancer growth in a laboratory setting.Until
Advanced colon cancer is the leading cause of cancer-related death in young American men and the second highest worldwide. In the majority of these patients, as the cancer advances it metastasizes to
The UCSF Helen Diller Family Comprehensive Cancer Center announced today the awarding of a Specialized Programs of Research Excellence (SPORE) grant by the National Cancer Institute (NCI) for a
Urothelial carcinoma (UC) is the second most common genitourinary cancer, leading to over 16,000 deaths a year in the U.S. Despite recent advances, the five-year survival rate for metastatic UC
Two new Pew Latin American fellows, Beatriz De Moraes, PhD, and Lilian Gomes de Oliveira, PhD, will each receive a $30,000 annual stipend for two years to support their work at the crossroads of immunology and neuroscience.
Chaz Langelier and team discover a partial explanation for why lupus gets better as patients age. It's because inflammation-related genes get muffled - the opposite of what usually happens in healthy aging - and inflammation is tempered.
Scientists discover how to rouse the immune system around "cold" tumors, making them vulnerable to cancer-killing immune therapies with checkpoint inhibitors.
A new study found that female hormones can suppress pain signals before they reach the brain by making immune cells near the spinal cord produce opioids.
A Q&A w/Alison Cohen, PhD, MPH, who is among the estimated 5% of the population with Long COVID. She talks through the implications of Long COVID, and how she applies her scientific and personal experience to research this debilitating condition.
COPA syndrome causes lung hemorrhaging starting in childhood. But one in three people with the disease mutation are spared. UCSF scientists have discovered how a separate gene variant protects those relatives – lighting the way to a possible cure.
UCSF scientists have found that some cancers, like brain cancer, make unique, jumbled proteins that make them stand out. These newly recognized cancer-specific proteins, or antigens, could speed the development of potent immunotherapies that recognize and attack hard-to-treat tumors.
